Dual Inhibition of TAF1 and BET Bromodomains from the BI-2536 Kinase Inhibitor Scaffold.

MLA

Remillard, David, et al. “Dual Inhibition of TAF1 and BET Bromodomains from the BI-2536 Kinase Inhibitor Scaffold.” ACS Medicinal Chemistry Letters, vol. 10, no. 10, Sept. 2019, pp. 1443–49. EBSCOhost, https://doi.org/10.1021/acsmedchemlett.9b00243.

APA

Remillard, D., Buckley, D. L., Seo, H.-S., Ferguson, F. M., Dhe-Paganon, S., Bradner, J. E., & Gray, N. S. (2019). Dual Inhibition of TAF1 and BET Bromodomains from the BI-2536 Kinase Inhibitor Scaffold. ACS Medicinal Chemistry Letters, 10(10), 1443–1449. https://doi.org/10.1021/acsmedchemlett.9b00243

Chicago

Remillard, David, Dennis L Buckley, Hyuk-Soo Seo, Fleur M Ferguson, Sirano Dhe-Paganon, James E Bradner, and Nathanael S Gray. 2019. “Dual Inhibition of TAF1 and BET Bromodomains from the BI-2536 Kinase Inhibitor Scaffold.” ACS Medicinal Chemistry Letters 10 (10): 1443–49. doi:10.1021/acsmedchemlett.9b00243.